Phil, curing cancer is all that matters. The little price movements are irrelevant and distract from what counts - I think you over-reacted and were unduly harsh and unkind to Schlepper. Management became obsessed with the money, the perks of office, process, furniture, and lost track of the thing which matters most - the people suffering the disease.
Obviously the money has to be organized, FDA rulz complied with, staff hired and stock options set up for staff and management.
Unfortunately, the Board saw fit to reward themselves for lack of performance by repricing options to an absurdly low level which low level was only achieved due to their mismanagement and arranging financing via a bottomless pit S3 offering. If Techniclone sold shares for cash instead of mucking around with business school fancy financing, things would be a lot more solid and shareholders would not have been involuntarily diluted.
If Techniclone cures cancer, there will be heaps of money to enjoy, assuming patents have been properly defined and protected, production and management is well organized and all the other stuff also done.
If you want to directly support the cause, your money wouldn't be better elsewhere if you think TNT, Oncolym, VTA, VEA and The Freezer have the best chances of killing big heaps of cancer cells. Investment in profit making companies is the best place to put money. Foundations, donations, charities and the like are money sinks with no real incentive to cure cancer. Keeping the money rolling in is the main thing for those. Investment in business and making big heaps of profit will attract billions and get results.
Techniclone price came a gutser because investors decided management was more interested in lifestyle than results. Fortunately, the technology is getting results at last, so the situation seems likely to be rescued.
Now that the results are obvious, will the FDA hold things up for some bureaucratic purpose and require hundreds if not thousands of people to die before their time as human sacrifice to the bureaucracy? Lucky, lucky glioma people, if you follow FDA reasoning, they won't die of TNT since safety has been proven - they can now go ahead and happily die of brain tumours instead. The FDA and Techniclone should be working shifts to get TNT to production.
Now that some good enough safety and efficacy is proven, the decision to use the product or not should be between the patient, their advising Oncologist and Techniclone. The FDA people should get real jobs. Maybe even be prosecuted in The Hague for Crimes Against Humanity if they delay a day and stop somebody getting treatment who wants it.
Making it illegal to be alive seems a greater abuse of power than Clinton trying to cover up a mistress. There are going to be dead people every day TNT is delayed. How come people aren't up in arms about that?
I hope these people who allowed themselves to be FDA/Techniclone/Oncologist/Medical Association/TCLN shareholder guinea pigs now get full TNT doses if they want them and get the best prospects of being cured. Or are they now just put on the scrap heap and left to die along with the other glioma patients who must wait for the bureaucracy to wend their leisurely way through lunch and many meetings?
Maurice |
